Optic Pathway Glioma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-07-26
Clinical Trial Update: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma [Phase 3]
A Phase 3 clinical trial comparing ANP Therapy with temozolomide for optic pathway glioma has been withdrawn.